Research progress on the therapeutic effects of polysaccharides on non-alcoholic fatty liver diseases

Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease and is a leading cause of cirrhosis and hepatocellular carcinoma. Due to its complex pathophysiology, there is currently no approved therapy. Polysaccharide, a kind of natural product, possesses a wide range o...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in nutrition (Lausanne) 2023-03, Vol.10, p.1107551-1107551
Main Authors: Hu, Yu-Long, Ma, Qiaoli, Dong, Xiaoqiang, Kong, Yuanfang, Cai, Juntao, Li, Jieming, Dong, Chunhong
Format: Article
Language:English
Subjects:
liver diseases
NAFLD
NASH
Nutrition
polysaccharides
therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c466t-f2660a0b4def4b287cc8052560aabdbb895d78cf8e82d80fe5664b7e8c7a046b3
cites cdi_FETCH-LOGICAL-c466t-f2660a0b4def4b287cc8052560aabdbb895d78cf8e82d80fe5664b7e8c7a046b3
container_end_page 1107551
container_issue
container_start_page 1107551
container_title Frontiers in nutrition (Lausanne)
container_volume 10
creator Hu, Yu-Long
Ma, Qiaoli
Dong, Xiaoqiang
Kong, Yuanfang
Cai, Juntao
Li, Jieming
Dong, Chunhong
description Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease and is a leading cause of cirrhosis and hepatocellular carcinoma. Due to its complex pathophysiology, there is currently no approved therapy. Polysaccharide, a kind of natural product, possesses a wide range of pharmacological activities. Numerous preclinical studies have confirmed that polysaccharides could interfere with the occurrence and development of NAFLD at multiple interrelated levels, such as improvement of glucose and lipid metabolism, antioxidation, anti-inflammation, and regulation of gut-liver axis, thus showing great potential as novel anti-NAFLD drugs. In this paper, we reviewed the polysaccharides with anti-NAFLD effect in recent years, and also systematically analyzed their possible pharmacological mechanisms.
doi_str_mv 10.3389/fnut.2023.1107551
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_1573d15a20914262a1a0dc9a7d92203a</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_1573d15a20914262a1a0dc9a7d92203a</doaj_id><sourcerecordid>2791706705</sourcerecordid><originalsourceid>FETCH-LOGICAL-c466t-f2660a0b4def4b287cc8052560aabdbb895d78cf8e82d80fe5664b7e8c7a046b3</originalsourceid><addsrcrecordid>eNpVkU1r3DAQhk1paUKaH9BL8bEXb_Qt-VRK6EcgECgt9CbG0mjtoLVcyQ7sv483uw3JQUjMvPNI4qmqj5RsODftVRiXecMI4xtKiZaSvqnOGWtVYxT9-_bF-ay6LOWeEEI5k4KK99UZV61qDaPnFf7CgpBdX085bTOWUqexnns8rAwTLvPgagwB3by2Qj2luC_gXA958PiUHtPYQHSpT3HNBpjnfR2HB8y1H1Z4wfKhehcgFrw87RfVn-_ffl__bG7vftxcf71tnFBqbgJTigDphMcgOma0c4ZIJtcidL7rTCu9Ni4YNMwbElAqJTqNxmkgQnX8oro5cn2CezvlYQd5bxMM9qmQ8tZCXj8U0VKpuacSGGmpYIoBBeJdC9q3jBEOK-vLkTUt3Q69w3HOEF9BX3fGobfb9GApIVxxIVbC5xMhp38LltnuhuIwRhgxLcUy3VJNlCZyjdJj1OVUSsbwfA8l9qDbHnTbg2570r3OfHr5wOeJ_3L5I52kqSg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2791706705</pqid></control><display><type>article</type><title>Research progress on the therapeutic effects of polysaccharides on non-alcoholic fatty liver diseases</title><source>PubMed Central</source><creator>Hu, Yu-Long ; Ma, Qiaoli ; Dong, Xiaoqiang ; Kong, Yuanfang ; Cai, Juntao ; Li, Jieming ; Dong, Chunhong</creator><creatorcontrib>Hu, Yu-Long ; Ma, Qiaoli ; Dong, Xiaoqiang ; Kong, Yuanfang ; Cai, Juntao ; Li, Jieming ; Dong, Chunhong</creatorcontrib><description>Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease and is a leading cause of cirrhosis and hepatocellular carcinoma. Due to its complex pathophysiology, there is currently no approved therapy. Polysaccharide, a kind of natural product, possesses a wide range of pharmacological activities. Numerous preclinical studies have confirmed that polysaccharides could interfere with the occurrence and development of NAFLD at multiple interrelated levels, such as improvement of glucose and lipid metabolism, antioxidation, anti-inflammation, and regulation of gut-liver axis, thus showing great potential as novel anti-NAFLD drugs. In this paper, we reviewed the polysaccharides with anti-NAFLD effect in recent years, and also systematically analyzed their possible pharmacological mechanisms.</description><identifier>ISSN: 2296-861X</identifier><identifier>EISSN: 2296-861X</identifier><identifier>DOI: 10.3389/fnut.2023.1107551</identifier><identifier>PMID: 36969821</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>liver diseases ; NAFLD ; NASH ; Nutrition ; polysaccharides ; therapy</subject><ispartof>Frontiers in nutrition (Lausanne), 2023-03, Vol.10, p.1107551-1107551</ispartof><rights>Copyright © 2023 Hu, Ma, Dong, Kong, Cai, Li and Dong.</rights><rights>Copyright © 2023 Hu, Ma, Dong, Kong, Cai, Li and Dong. 2023 Hu, Ma, Dong, Kong, Cai, Li and Dong</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c466t-f2660a0b4def4b287cc8052560aabdbb895d78cf8e82d80fe5664b7e8c7a046b3</citedby><cites>FETCH-LOGICAL-c466t-f2660a0b4def4b287cc8052560aabdbb895d78cf8e82d80fe5664b7e8c7a046b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036344/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036344/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27922,27923,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36969821$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hu, Yu-Long</creatorcontrib><creatorcontrib>Ma, Qiaoli</creatorcontrib><creatorcontrib>Dong, Xiaoqiang</creatorcontrib><creatorcontrib>Kong, Yuanfang</creatorcontrib><creatorcontrib>Cai, Juntao</creatorcontrib><creatorcontrib>Li, Jieming</creatorcontrib><creatorcontrib>Dong, Chunhong</creatorcontrib><title>Research progress on the therapeutic effects of polysaccharides on non-alcoholic fatty liver diseases</title><title>Frontiers in nutrition (Lausanne)</title><addtitle>Front Nutr</addtitle><description>Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease and is a leading cause of cirrhosis and hepatocellular carcinoma. Due to its complex pathophysiology, there is currently no approved therapy. Polysaccharide, a kind of natural product, possesses a wide range of pharmacological activities. Numerous preclinical studies have confirmed that polysaccharides could interfere with the occurrence and development of NAFLD at multiple interrelated levels, such as improvement of glucose and lipid metabolism, antioxidation, anti-inflammation, and regulation of gut-liver axis, thus showing great potential as novel anti-NAFLD drugs. In this paper, we reviewed the polysaccharides with anti-NAFLD effect in recent years, and also systematically analyzed their possible pharmacological mechanisms.</description><subject>liver diseases</subject><subject>NAFLD</subject><subject>NASH</subject><subject>Nutrition</subject><subject>polysaccharides</subject><subject>therapy</subject><issn>2296-861X</issn><issn>2296-861X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkU1r3DAQhk1paUKaH9BL8bEXb_Qt-VRK6EcgECgt9CbG0mjtoLVcyQ7sv483uw3JQUjMvPNI4qmqj5RsODftVRiXecMI4xtKiZaSvqnOGWtVYxT9-_bF-ay6LOWeEEI5k4KK99UZV61qDaPnFf7CgpBdX085bTOWUqexnns8rAwTLvPgagwB3by2Qj2luC_gXA958PiUHtPYQHSpT3HNBpjnfR2HB8y1H1Z4wfKhehcgFrw87RfVn-_ffl__bG7vftxcf71tnFBqbgJTigDphMcgOma0c4ZIJtcidL7rTCu9Ni4YNMwbElAqJTqNxmkgQnX8oro5cn2CezvlYQd5bxMM9qmQ8tZCXj8U0VKpuacSGGmpYIoBBeJdC9q3jBEOK-vLkTUt3Q69w3HOEF9BX3fGobfb9GApIVxxIVbC5xMhp38LltnuhuIwRhgxLcUy3VJNlCZyjdJj1OVUSsbwfA8l9qDbHnTbg2570r3OfHr5wOeJ_3L5I52kqSg</recordid><startdate>20230310</startdate><enddate>20230310</enddate><creator>Hu, Yu-Long</creator><creator>Ma, Qiaoli</creator><creator>Dong, Xiaoqiang</creator><creator>Kong, Yuanfang</creator><creator>Cai, Juntao</creator><creator>Li, Jieming</creator><creator>Dong, Chunhong</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20230310</creationdate><title>Research progress on the therapeutic effects of polysaccharides on non-alcoholic fatty liver diseases</title><author>Hu, Yu-Long ; Ma, Qiaoli ; Dong, Xiaoqiang ; Kong, Yuanfang ; Cai, Juntao ; Li, Jieming ; Dong, Chunhong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c466t-f2660a0b4def4b287cc8052560aabdbb895d78cf8e82d80fe5664b7e8c7a046b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>liver diseases</topic><topic>NAFLD</topic><topic>NASH</topic><topic>Nutrition</topic><topic>polysaccharides</topic><topic>therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hu, Yu-Long</creatorcontrib><creatorcontrib>Ma, Qiaoli</creatorcontrib><creatorcontrib>Dong, Xiaoqiang</creatorcontrib><creatorcontrib>Kong, Yuanfang</creatorcontrib><creatorcontrib>Cai, Juntao</creatorcontrib><creatorcontrib>Li, Jieming</creatorcontrib><creatorcontrib>Dong, Chunhong</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in nutrition (Lausanne)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hu, Yu-Long</au><au>Ma, Qiaoli</au><au>Dong, Xiaoqiang</au><au>Kong, Yuanfang</au><au>Cai, Juntao</au><au>Li, Jieming</au><au>Dong, Chunhong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Research progress on the therapeutic effects of polysaccharides on non-alcoholic fatty liver diseases</atitle><jtitle>Frontiers in nutrition (Lausanne)</jtitle><addtitle>Front Nutr</addtitle><date>2023-03-10</date><risdate>2023</risdate><volume>10</volume><spage>1107551</spage><epage>1107551</epage><pages>1107551-1107551</pages><issn>2296-861X</issn><eissn>2296-861X</eissn><abstract>Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease and is a leading cause of cirrhosis and hepatocellular carcinoma. Due to its complex pathophysiology, there is currently no approved therapy. Polysaccharide, a kind of natural product, possesses a wide range of pharmacological activities. Numerous preclinical studies have confirmed that polysaccharides could interfere with the occurrence and development of NAFLD at multiple interrelated levels, such as improvement of glucose and lipid metabolism, antioxidation, anti-inflammation, and regulation of gut-liver axis, thus showing great potential as novel anti-NAFLD drugs. In this paper, we reviewed the polysaccharides with anti-NAFLD effect in recent years, and also systematically analyzed their possible pharmacological mechanisms.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>36969821</pmid><doi>10.3389/fnut.2023.1107551</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2296-861X
ispartof Frontiers in nutrition (Lausanne), 2023-03, Vol.10, p.1107551-1107551
issn 2296-861X
2296-861X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_1573d15a20914262a1a0dc9a7d92203a
source PubMed Central
subjects liver diseases
NAFLD
NASH
Nutrition
polysaccharides
therapy
title Research progress on the therapeutic effects of polysaccharides on non-alcoholic fatty liver diseases
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T10%3A12%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Research%20progress%20on%20the%20therapeutic%20effects%20of%20polysaccharides%20on%20non-alcoholic%20fatty%20liver%20diseases&rft.jtitle=Frontiers%20in%20nutrition%20(Lausanne)&rft.au=Hu,%20Yu-Long&rft.date=2023-03-10&rft.volume=10&rft.spage=1107551&rft.epage=1107551&rft.pages=1107551-1107551&rft.issn=2296-861X&rft.eissn=2296-861X&rft_id=info:doi/10.3389/fnut.2023.1107551&rft_dat=%3Cproquest_doaj_%3E2791706705%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c466t-f2660a0b4def4b287cc8052560aabdbb895d78cf8e82d80fe5664b7e8c7a046b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2791706705&rft_id=info:pmid/36969821&rfr_iscdi=true